©ñ¤j¹Ï¤ù
±ç¦ë
¾¨ºÞ¬ü°ê´N·~¼Æ¾Ú¦nÃa°Ñ¥b¡A¤£¹L10¤ë¥¢·~²v°¨ì6¦~¨Ó·s§Cªº5.8%¡A¿EÀy¹D«ü¡B¼Ð´¶500«ü¼Æ¤W©P¤³sÄò²Ä¤T¤Ñ¦¬½L¨ê·s¾ú¥v¬ö¿ý¡A¨âªÌ¥þ©P¤À§O¦³1.05%»P0.69%º¦´T¡A¦b¥þ²yªÑ¥«º¦´Tº]¤W¤À©~²Ä¤©M²Ä¤K¤§¾l¡A¥B¬°³sÄò¤T©P¦¬¬õ¡C¦b¹L¥h12¦~¡A¬ü°ê¤¤´Á¿ïÁ|«á¤@Ó¤ë¦Ü¤TӤ뤺ªÑ¥«¦h¦³2%¦Ü3.5%ªº¼Wªø¡A¥[¤W¥ø·~¬Õ§Q¹w´ú¤W½Õ¡A¦³§Q¬üªÑÄò¤W¤É¡A§ë¸êªÌ¥i¦ø¾÷§l¯Ç¬ÛÃö¬üªÑ°òª÷¡C
¥Ñ©ó¥«³õ¹ï©ó¬ü°ê¶q¼e(QE)§¹¥þ°h¥«¤w¦³¤ß²z¹w´Á¡A°ê»Ú¸êª÷¾aÃl·ÀI©Ê¸ê²£¡A¿EÀy¬ü¶×«ü¼ÆÂà±j¡A¥[¤W¼Ð´¶500¦¨¥÷ªÑ¦Ü¤W¤ë©³¦X¦@347®a¤½¥¬©u«×°]³øªº¥ø·~¤¤¡A¦³75%¬OÀu©ó¹w´Á¡A¾ãÅé¬Õ§Q¸û¥h¦~¦P©u¼Wªø6.9%¡AÅý¬üªÑ¦b10¤ë³Ì«á¤@©P²b¬y¤J±µªñ150»õ¤¸(¬ü¤¸¡A¤U¦P)¸êª÷ª÷ÃB¡C
¦Ó10¤ë²Öp²b¬y¤J¬ù391»õ¤¸ªºª÷ÃB¡A¬°¥h¦~8¤ë¥H¨Ó³æ¤ë¬y¤Jª÷ÃBªº·s°ª¡C¶i¤J11¤ë¡A¬üªÑ¹L¥h1©P¨ü¦@©MÄÒ¦b°ê·|¤¤´Á¤j¿ï³Ó¥X¡B¥ø·~¬Õ§Q±j«l»P¥«³õ´¢´ú¼Ú¬w¥¡¦æ±NÂX¤j³f¹ô¨ë¿Eµ¥§Q¦n¦]¯À¿EÀy¡AÅý¬üªÑ¨ü´f¼ÖÆ[®ðª^ªº°Ê¯à¡C
¥H¦ûªñ¤TÓ¤ëº]ºªº´IÄõ§JªL¬ü°êªÑ²¼°òª÷¬°¨Ò¡A¥Dn¬O³z¹L¬ü°ê¥DnÃÒ¥æ©Ò¥æ©öªºÃÒ¨é¡B¹w°UÃÒ¨é¥H¤Î¥i´«ªÑ¶ÅªººÞ²z²Õ¦X¡A¥H¹FPªø´Á¸ê¥»¼WȪº§ë¸êµ¦²¤¥Ø¼Ð¡C
¸Ó°òª÷¦b2011¡B2012©M2013¦~ªí²{¤À§O¬°-3.9%¡B10.33%¤Î27.03%¡C°òª÷¥§¡¥«¬Õ²v¡Bªñ¤T¦~ªº¼Ð·Ç®t¡B®L´¶¤ñ²v»P¨©¥LȬ°18.29¿¡B9.11%¡B0.13¤Î0.84¡C
¸ê²£¦æ·~¤ñ«¬°22.87%¸ê°T¬ì§Þ¡B19.2%°·±dÅ@²z¡B19.14%ª÷¿ÄªA°È¡B10.15%«D¥²»Ý«~®ø¶O¡B9.65%¯à·½¡B9.57%¤u·~¡B6.64%ì§÷®Æ¤Î2.78%¥²»Ý«~®ø¶O¡C
¸ê²£¦Ê¤À¤ñ¬°97.45%ªÑ²¼¤Î2.55%³f¹ô¥«³õ¡C°òª÷¤T¤j¸ê²£¤ñ«ªÑ²¼¬°5.6%Valeant Pharmaceuticals International¡B4.3%Actavis Plc.¤Î4.3%Hartford Financial Services Group¡C
¬ü°ê¤¤´Á¿ïÁ|«áªÑ¥«¦h¨Ò¤É
§Y«K¹D«ü¡B¼Ð´¶500¤µ¦~¤À§O²Öp¤wº¦6.02%©M9.93%¡AÁa¨Ï¥¼¨Ó¤£¯à¦A´Á±æ¬üªÑ¦³¦ôÈÂX±i¡A¤£¹L¥Ñ©ó¥¢·~²vèB§ïµ½¡A¸gÀÙ«ùÄò·Å©M§ïµ½¡AªÑ¥«ÁÙ¦³±æ¨ü´f¥ø·~¬Õ§Q»PªÑ®§¼W¥[µ¥¥ø·~°ò¥»±¦]¯À±a°Ê¡C
¦¹¥~¡A¦³²Îp¦Û2002¦~°_¡A°£¤F2008¦~ª÷¿Ä®ü¼S¥þ²yªÑ¥««®Àªº¦~«×¡A¬üªÑ¤¤´Á¿ïÁ|«á¤@Ó¤ë¦Ü¤TÓ¤ë¡A¥§¡ÁÙ¦³2%¦Ü3.5%ªºº¦´T¡A¥[¤W¹L¥h¬üªÑ¥ø·~¬Õ§Q¹w¦ôÁͶեѤU½Õ§áÂର¤W½Õ¡A·N¨ýþÓ¬üªÑ¤µ¦~³Ì«á¨âÓ¤ë¥i±æ§ó¤W¼h¼Ó¡C
|